Mucosal leishmaniasis (ML) is a complication of New World cutaneous leishmaniasis (CL)
caused mainly by Leishmania (Viannia) braziliensis. This retrospective study investigated all …

Background: Mucosal leishmaniasis (ML) is an important complication of new world
cutaneous leishmaniasis (CL) caused by species of the Leishmania Viannia subgenus …

Background Leishmaniases are regularly seen in non-endemic areas due to the increase of
international travels. They include cutaneous leishmaniases (CL) and mucocutaneous (MC) …

Introduction Mucocutaneous leishmaniasis (MCL) is a complication of tegumentary
leishmaniasis, causing potentially life-threatening lesions in the ear, nose, and throat (ENT) …

Background Cutaneous leishmaniasis (CL) is frequent in travellers and can involve oro-
nasal mucosae. Clinical presentation impacts therapeutic management. Methodology …

Background Cutaneous leishmaniasis (CL) may be emerging among international travellers
and migrants. Limited data exist on mucocutaneous leishmaniasis (MCL) in travellers. We …

Background Cutaneous leishmaniasis (CL), a parasitic disease which represents a public
health problem, particularly in Central and South America, has become a leading condition …

Mucosal leishmaniasis (ML) is observed only in about 3% of patients with American
tegumentary leishmaniasis (ATL) but has a high potential for destructive, disfiguring, and …

Infection with protozoan parasites of the genus Leishmania leads to a wide variety of clinical
disease syndromes called leishmaniasis, or more appropriately the leishmaniases [1]. The …

Discussion Members of the Leishmania (Viannia) subgenus are known to cause destructive
lesions of the nasal, oral, and hypopharyngeal mucosa. Mucosal involvement is rare in …